PIEZO1 and idiopathic pulmonary fibrosis: Our findings highlight mechanical signaling as a core driver of fibrosis, and we believe that targeting Postn-expressing cells and PIEZO1 is a novel potential approach to develop effective drugs for treatment of fibrotic diseases such as IPF.